Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …

Combination antiretroviral therapy (cART) has extended the longevity of human immunodeficiency
virus (HIV)-infected individuals. However, this has resulted in greater awareness of …

(See the editorial commentary by Flanigan and Beckwith, on pages 1201–3 .) Background.
Although some studies have identified impressive clinical gains for incarcerated HIV-…

Background Barriers to HIV treatment among injection drug users (IDU) are a major public
health concern. However, there remain few long-term studies investigating key demographic …

Despite the advent of effective antiretroviral therapy (ART), HIV-seropositive injection drug
users (IDU) continue to suffer from elevated levels of morbidity and mortality. Evidence is …

Objectives: To estimate the incidence of and risk factors for emergent resistance to integrase
strand transfer inhibitor (INSTI) and nucleoside (-tide) reverse transcriptase inhibitors (NRTI…

Aims Despite proven benefits of antiretroviral therapy (ART), many human immunodeficiency
virus (HIV)‐infected injection drug users (IDU) do not access treatment even in settings with …

Pulmonary function has been extensively studied in unilateral diaphragmatic paralysis (UDP),
but there is scarce information regarding inspiratory muscle function in this condition. We …

Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a third …

Objective Cardiovascular disease (CVD) is one of the leading non-AIDS-defining causes of
death among HIV-positive (HIV+) individuals. However, the evidence surrounding specific …